CE Holdings (4320) Q1 2025 earnings summary

Executive summary

• Achieved record-high quarterly revenue and profits, with Q1 FY2025 revenue up 19.8% to ¥3,797 million, driven by strong sales and maintenance of electronic medical record systems and cost reductions in SG&A expenses.

• Operating income surged 108.4% to ¥390 million, and net income attributable to shareholders increased 345.3% to ¥200 million, both record highs.

• Orders received and order backlog reached record levels, up 93.8% and 40.5% year-over-year, respectively.

Financial highlights

• Gross profit for Q1 FY2025 was ¥913 million, up 18.2% year-over-year.

• Operating margin improved significantly due to higher sales and reduced SG&A expenses, with operating profit at ¥390 million (up 108.4%).

• Net income per share for the quarter was ¥13.28, compared to ¥3.01 in the prior year.

• Comprehensive income for the quarter was ¥231 million, up 353.1% year-over-year.

• Net income attributable to shareholders reached ¥200 million, up 345.3% year-over-year.

Outlook and guidance

• Full-year guidance unchanged: revenue projected at ¥15,000 million (+3.1%), operating income at ¥1,500 million (+30.6%), and net income at ¥820 million (+564.4%) year-over-year.

• Forecasts anticipate record highs for revenue, operating, and net income.

• Dividend forecast for FY2025 is ¥22 per share, up from ¥18 last year.